$EXHI .0055 up 20% on NEWS! $EXHI is in the medical device
$EXHI .0055 up 20% on NEWS! $EXHI is in the medical device industry with a float of only 1.9M ~ the 52 week range is .0031 - .215 with no R/S! >>> Exlites Issues a Letter of Intent to Purchase a Medical Device Company http://www.stockwatch.com/News/Item.aspx?bid=...p;region=U 2013-11-18 07:01 ET - News Release Salt Lake City, UT, (eTeligis.com) Exlites Holdings International, Inc. (OTCPINK: EXHI) announced that it has issued a Letter of Intent ("LOI") to purchase a medical device company that will provide an existing sales force in proven markets with next generation products. Under the LOI, Exlites will provide use its stock to complete the acquisition and purchase 100% of the target company's issued and outstanding common stock, which will make the target company a wholly-owned subsidiary of Exlites. Exlites' CEO, Joseph Chung, stated that the acquisition should be completed within the next two weeks. The acquisition will increase the Company's product offerings and provide for new distribution channels and a seasoned sales force, Chung stated. Exlites was incorporated in the U.S., and until recently, was mainly engaged in business in Japan. Recently, management determined that it was in the Company's best interest to enter the larger U.S. medical equipment market and take advantage of its relationships. Exlites business model is unique in that the Company strives to provide assistance and resources to certain medical equipment manufacturers, many of whom are overseas, are more cost effective and may require FDA approval. By partnering with these medical equipment companies, Exlites can obtain better pricing for the best quality products for its customers. Exlites' business plan includes assisting manufacturers to obtain FDA registration and approval. About Exlites Holdings International Inc. Exlites Holdings International Inc. was operated in Japan for a number of years before moving to the United States. The Company's products are sold online and through the company's affiliate and distribution programs. The Company is dedicated to offering medical equipment to hospitals, assisted living facilities and to private individuals who seek quality medical equipment at cost effective prices. The Company's website is at http://www.exlitesmedical.com . CONTACT: Exlites Holdings International, Inc. info@exlitesmedical.com SOURCE: Exlites Holdings International, Inc. Chart: http://stockcharts.com/h-sc/ui?s=exhi
Corporate Website: http://www.exlitesmedical.com OTC Market Corporate Info: http://www.otcmarkets.com/stock/EXHI/quote
Scroll down for more posts ▼
Top 10 Most Recent News Articles
New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...
Continue Reading
A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...
Continue Reading
Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...
Continue Reading
The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...
Continue Reading
Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...
Continue Reading
Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...
Continue Reading
The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...
Continue Reading
A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...
Continue Reading
Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...
Continue Reading
Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...
Continue Reading
Top 5 Most Recently Viewed Articles
Rockwell Automation Enhances Lucid's EV Manufacturing Rockwell Automation, Inc. (NYSE: ROK), renowned for its commitment to industrial automation and digital transformation, is set to significantly enhance the electric vehicle (EV) production capabilities for Lucid. This collaboration aligns with Saudi Arabia's Vision 2030, aiming to develop a sustainable and diversified...
Continue Reading
TeraWulf Stock Overview TeraWulf Inc. (NASDAQ: WULF) is observing fluctuations in its stock value amidst significant financial developments. The company's stock experienced a minor drop of 0.96%, settling at $9.29 in pre-market trading. Investors are closely monitoring the implications of recent announcements on the company's future Convertible Notes Offering Details...
Continue Reading
Kaltura got analysts buzzing back in 2024 with their second-quarter results that had the desks reeling. Adjusted EBITDA hit $1.6 million when everyone was just hoping for $0.2 million. Revenue? $44 million, up from the expected $43.1 million—these numbers showed Kaltura wasn’t just treading water; they were swimming against the tide. Kaltura's Performance Metrics: A...
Continue Reading
Nvidia's Rise as a Technological Powerhouse Nvidia Corporation (NASDAQ: NVDA) has reached a new peak in its market valuation, crossing a staggering $4 trillion. Investors have welcomed the recent news regarding the resumption of sales of its advanced AI chips, boosting trust in the company's future prospects. This surge heightens interest in Nvidia, showcasing a potential...
Continue Reading
Oil Prices Facing Declines Recent trends indicate that oil prices have been on a downward trajectory, particularly influenced by uncertainties surrounding geopolitical tensions and tariffs imposed by the U.S. However, a critical observation is that these factors intertwine to significantly affect global economic conditions and energy demand. Current Status of Oil Pricing...
Continue Reading